相关实验视频

Updated: May 14, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

基于机器学习的策略预测了针对复发性急性髓性白血病的选择性和协同药物组合

Yingjia Chen¹, Liye He¹, Aleksandr Ianevski¹

¹University of Helsinki, Helsinki, Finland.

Cancer research

|May 12, 2025

概括

机器学习优先考虑治疗复发性/耐药性急性髓性白血病 (AML) 的药物组合. 这种方法准了耐治疗的AML细胞,改善了个性化治疗策略,以获得更好的患者结果.

科学领域:

在瘤学瘤学.
计算生物学计算生物学
药理学药理学是指药理学的学科.

背景情况:

耐药性或复发性急性髓性白血病 (AML) 需要改进治疗策略.
药物组合测试是具有挑战性的,因为患者材料有限,可能性众多.
患者异质性需要个性化的方法来克服耐药性.

研究的目的:

开发一种基于机器学习的策略,以优先考虑在复发性/耐药性 (R/R) AML 中的药物组合.
确定针对患者特异性弱点和耐药细胞群的个性化组合疗法.
通过细胞种群特定测试和临床试验数据验证预测方法.

主要方法:

从初级AML样本中利用单细胞转录组学和单剂反应概况.
采用系统的组合设计策略与机器学习来优先考虑药物组合.
进行细胞群体特定的药物组合测试,以评估协同作用和效力.

主要成果:

该方法确定了在单个AML患者中协同抑制耐治疗癌细胞的向组合.
针对患者的,根据疾病阶段量身定制的组合预测表明了R/RAML细胞的协同作用和效力.
预先的实验预测了venetoclax-azacitidine联合治疗AML患者的临床结果.

结论:

一种计算实验方法合理地确定了针对R/R AML的个性化组合方案.
该策略针对耐治疗白血病细胞,提高临床转换的可能性.
个性化药物组合对于克服AML的患者间和患者内异质性至关重要.

更多相关视频

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...